VeTreat
Autonomous and Needle-Free Cattle Injection System
Company Overview
Snapshot
Founded in July 2024, VeTreat operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing an autonomous, AI-based, needle-free injection system for livestock. VeTreat is actively engaged in R&D, leveraging advanced computer vision and proprietary AI developed under the NVIDIA Inception program.
Business overview
VeTreat develops an autonomous, AI-based, needle-free injection system for livestock, specifically targeting cattle in dairy and beef operations. Its core technology automates vaccination and treatment processes without human involvement, utilizing advanced computer vision and proprietary AI to identify animals, select optimal injection sites, and administer precise dosages. The system aims to enhance accuracy, animal welfare, and operational efficiency, while reducing risks to farm workers and lowering operational costs. VeTreat's solution provides integrated data analytics for performance monitoring, supporting improved herd health management and compliance within the agriculture and food technologies sector.
Log in to access full profile ›Company Intelligence Q&A
- What is VeTreat's primary product?
- VeTreat's primary product is the VeTreat CowCare, an autonomous, AI-based, needle-free injection system designed for livestock, initially focusing on cattle in dairy and beef operations.
- When was VeTreat founded?
- VeTreat was founded in July 2024.
- What technology does VeTreat utilize for its injection system?
- VeTreat utilizes advanced computer vision and proprietary AI, developed under the NVIDIA Inception program, to identify animals, select optimal injection sites, and administer precise dosages.
- Which markets does VeTreat target?
- VeTreat targets geomarkets including Australia, Europe, Israel, Canada, South America, and the United States.
- What is the current product stage of VeTreat's solution?
- VeTreat's product, the VeTreat CowCare, is currently in the Research and Development (R&D) stage, with development ongoing since the company's founding in July 2024.